Trial of Atezolizumab and Bevacizumab With CHS-388 or Placebo in Patients With Hepatocellular Carcinoma
Trial details
- Registry ID
- NCT05359861
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Trial of Atezolizumab and Bevacizumab With CHS-388 or Placebo in Patients With Hepatocellular CarcinomaNCT05359861 | CHRS | Phase 2 | Terminated | 2025-06-30Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |